Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 4 art units • 5 examiners • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Lung Biotechnology Pbc has 8 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed among 5 distinct examiners and 4 distinct art units, showing meaningful concentration at both the examiner and art-unit levels. Several matters therefore share examination personnel or organizational context.
ZHU, JIANJIAN is the busiest examiner, with 3 pending matters. That concentration makes the examiner’s handling of related claim language, prior-art issues, and procedural requests especially relevant to coordinated prosecution planning.
The profile supports a two-level management approach. Counsel can use shared examiner and art-unit assignments to identify recurring themes, while preserving matter-specific analysis where claim scope or cited references differ. Centralized tracking is important for maintaining consistency across the pending biotechnology matters.
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 7 (88%) |
| Multi-statute (no §101) | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHU, JIANJIAN | 3 | 58.1% | +82.5% |
| CHIDIAC, NICHOLAS J | 2 | 54.5% | +34.6% |
| MOLOYE, TITILAYO | 1 | 62.3% | +48.3% |
| LENIHAN, JEFFREY S | 1 | 73.0% | +17.0% |
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18354205 | Methods for Differentiating Stromal Cells or Pericytes | CANDELARIA, JULIANA IRENE | 35d |
| 18226635 | INTERPENETRATING POLYMER NETWORKS FOR USE IN SUTURABLE AND FLEXIBLE MATERIALS | LENIHAN, JEFFREY S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18734286 | HIGH RESOLUTION PRINTING SYSTEM AND A METHOD OF ALIGNING PIXELATED TILES | CHIDIAC, NICHOLAS J | 49d overdue |
| 17410159 | APPARATUS AND METHOD IN 3D PRINTING | CHIDIAC, NICHOLAS J | 15d overdue |
| 18354210 | Methods for Differentiating Epithelial or Basal Cells | ZHU, JIANJIAN | 9d |
| 18227001 | ADVANCED MANUFACTURED TRANSWELL USING SYNTHETIC BIOINK FOR CELL CULTURE AND IN VITRO TISSUE MODELS | ZHU, JIANJIAN | 22d |
| 18611429 | POST-PROCESSING OF BIOLOGICAL SCAFFOLDS | MOLOYE, TITILAYO | — |
| 18226635 | INTERPENETRATING POLYMER NETWORKS FOR USE IN SUTURABLE AND FLEXIBLE MATERIALS | LENIHAN, JEFFREY S | — |
| 17738694 | USE OF FUNCTIONALIZED AND NON-FUNCTIONALIZED ECMS, ECM FRAGMENTS, PEPTIDES AND BIOACTIVE COMPONENTS TO CREATE CELL ADHESIVE 3D PRINTED OBJECTS | ZHU, JIANJIAN | — |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1744 | 2 |
| 1765 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18734286 | HIGH RESOLUTION PRINTING SYSTEM AND A METHOD OF ALIGNING PIXELATED TILES | CHIDIAC, NICHOLAS J | 1744 | §103 | Non-Final OA | 49d overdue | Pending | Jun 05, 2024 |
| 18611429 | POST-PROCESSING OF BIOLOGICAL SCAFFOLDS | MOLOYE, TITILAYO | — | §103 | Final Rejection | — | Pending | Mar 20, 2024 |
| 18227001 | ADVANCED MANUFACTURED TRANSWELL USING SYNTHETIC BIOINK FOR CELL CULTURE AND IN VITRO TISSUE MODELS | ZHU, JIANJIAN | 1631 | §103 | Final Rejection | 22d | Pending | Jul 27, 2023 |
| 18226635 | INTERPENETRATING POLYMER NETWORKS FOR USE IN SUTURABLE AND FLEXIBLE MATERIALS | LENIHAN, JEFFREY S | 1765 | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18354205 | Methods for Differentiating Stromal Cells or Pericytes | CANDELARIA, JULIANA IRENE | 1634 | §103 | Final Rejection | 35d | Pending | Jul 18, 2023 |
| 18354210 | Methods for Differentiating Epithelial or Basal Cells | ZHU, JIANJIAN | 1631 | §103 | Final Rejection | 9d | Pending | Jul 18, 2023 |
| 17738694 | USE OF FUNCTIONALIZED AND NON-FUNCTIONALIZED ECMS, ECM FRAGMENTS, PEPTIDES AND BIOACTIVE COMPONENTS TO CREATE CELL ADHESIVE 3D PRINTED OBJECTS | ZHU, JIANJIAN | 1631 | §103 | Non-Final OA | — | Pending | May 06, 2022 |
| 17410159 | APPARATUS AND METHOD IN 3D PRINTING | CHIDIAC, NICHOLAS J | 1744 | §103 | Final Rejection | 15d overdue | Pending | Aug 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLung Biotechnology Pbc has 8 pending office actions as of October 2026, spread across 4 art units and 5 examiners.
Jianjian Zhu has the most, with 3 of Lung Biotechnology Pbc's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
